FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127262560> ?p ?o ?g. }

• W3127262560 endingPage "173922" @default.
• W3127262560 startingPage "173922" @default.
• W3127262560 abstract "The coronavirus disease (COVID-19) is spreading between human populations mainly through nasal droplets. Currently, the vaccines have great hope, but it takes years for testing its efficacy in human. As there is no specific drug treatment available for COVID-19 pandemic, we explored in silico repurposing of drugs with dual inhibition properties by targeting transmembrane serine protease 2 (TMPRSS2) and human angiotensin-converting enzyme 2 (ACE2) from FDA-approved drugs. The TMPRSS2 and ACE2 dual inhibitors in COVID-19 would be a novel antiviral class of drugs called “entry inhibitors.” For this purpose, approximately 2800 US-FDA approved drugs were docked using a virtual docking tool with the targets TMPRSS2 and ACE2. The best-fit drugs were selected as per docking scores and visual outcomes. Later on, drugs were selected on the basis of molecular dynamics simulations. The drugs alvimopan, arbekacin, dequalinum, fleroxacin, lopinavir, and valrubicin were shortlisted by visual analysis and molecular dynamics simulations. Among these, lopinavir and valrubicin were found to be superior in terms of dual inhibition. Thus, lopinavir and valrubicin have the potential of dual-target inhibition whereby preventing SARS-CoV-2 entry to the host. For repurposing of these drugs, further screening in vitro and in vivo would help in exploring clinically." @default.
• W3127262560 created "2021-02-15" @default.
• W3127262560 creator A5000097762 @default.
• W3127262560 creator A5018650650 @default.
• W3127262560 creator A5074204507 @default.
• W3127262560 creator A5082793362 @default.
• W3127262560 creator A5085611281 @default.
• W3127262560 creator A5088742364 @default.
• W3127262560 date "2021-04-01" @default.
• W3127262560 modified "2023-09-28" @default.
• W3127262560 title "SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study" @default.
• W3127262560 cites W1985588649 @default.
• W3127262560 cites W1988152669 @default.
• W3127262560 cites W1992842793 @default.
• W3127262560 cites W2004343588 @default.
• W3127262560 cites W2023976810 @default.
• W3127262560 cites W2027423337 @default.
• W3127262560 cites W2031168104 @default.
• W3127262560 cites W2035067251 @default.
• W3127262560 cites W2041640654 @default.
• W3127262560 cites W2049902088 @default.
• W3127262560 cites W2076154818 @default.
• W3127262560 cites W2129153475 @default.
• W3127262560 cites W2138043907 @default.
• W3127262560 cites W2221309063 @default.
• W3127262560 cites W2253717482 @default.
• W3127262560 cites W2330799739 @default.
• W3127262560 cites W2341121880 @default.
• W3127262560 cites W2472351724 @default.
• W3127262560 cites W2912818999 @default.
• W3127262560 cites W2918508468 @default.
• W3127262560 cites W3007643904 @default.
• W3127262560 cites W3009335299 @default.
• W3127262560 cites W3009912996 @default.
• W3127262560 cites W3011000723 @default.
• W3127262560 cites W3012379316 @default.
• W3127262560 cites W3012565918 @default.
• W3127262560 cites W3013525829 @default.
• W3127262560 cites W3014203610 @default.
• W3127262560 cites W3014306106 @default.
• W3127262560 cites W3015606451 @default.
• W3127262560 cites W3015708777 @default.
• W3127262560 cites W3016885747 @default.
• W3127262560 cites W3021577619 @default.
• W3127262560 cites W3023606094 @default.
• W3127262560 cites W3031793601 @default.
• W3127262560 cites W3032742287 @default.
• W3127262560 cites W3042860993 @default.
• W3127262560 cites W3046074789 @default.
• W3127262560 cites W3046446544 @default.
• W3127262560 cites W3085112856 @default.
• W3127262560 cites W3092005914 @default.
• W3127262560 doi "https://doi.org/10.1016/j.ejphar.2021.173922" @default.
• W3127262560 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8060391" @default.
• W3127262560 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33539819" @default.
• W3127262560 hasPublicationYear "2021" @default.
• W3127262560 type Work @default.
• W3127262560 sameAs 3127262560 @default.
• W3127262560 citedByCount "27" @default.
• W3127262560 countsByYear W31272625602021 @default.
• W3127262560 countsByYear W31272625602022 @default.
• W3127262560 countsByYear W31272625602023 @default.
• W3127262560 crossrefType "journal-article" @default.
• W3127262560 hasAuthorship W3127262560A5000097762 @default.
• W3127262560 hasAuthorship W3127262560A5018650650 @default.
• W3127262560 hasAuthorship W3127262560A5074204507 @default.
• W3127262560 hasAuthorship W3127262560A5082793362 @default.
• W3127262560 hasAuthorship W3127262560A5085611281 @default.
• W3127262560 hasAuthorship W3127262560A5088742364 @default.
• W3127262560 hasBestOaLocation W31272625601 @default.
• W3127262560 hasConcept C103637391 @default.
• W3127262560 hasConcept C103697762 @default.
• W3127262560 hasConcept C104317684 @default.
• W3127262560 hasConcept C126322002 @default.
• W3127262560 hasConcept C142462285 @default.
• W3127262560 hasConcept C159047783 @default.
• W3127262560 hasConcept C18903297 @default.
• W3127262560 hasConcept C2522874641 @default.
• W3127262560 hasConcept C2775905019 @default.
• W3127262560 hasConcept C2777182164 @default.
• W3127262560 hasConcept C2778042024 @default.
• W3127262560 hasConcept C2779134260 @default.
• W3127262560 hasConcept C2779298103 @default.
• W3127262560 hasConcept C2780035454 @default.
• W3127262560 hasConcept C2993143319 @default.
• W3127262560 hasConcept C3008058167 @default.
• W3127262560 hasConcept C519536355 @default.
• W3127262560 hasConcept C524204448 @default.
• W3127262560 hasConcept C55493867 @default.
• W3127262560 hasConcept C60644358 @default.
• W3127262560 hasConcept C70721500 @default.
• W3127262560 hasConcept C71924100 @default.
• W3127262560 hasConcept C74187038 @default.
• W3127262560 hasConcept C86803240 @default.
• W3127262560 hasConcept C98274493 @default.
• W3127262560 hasConceptScore W3127262560C103637391 @default.
• W3127262560 hasConceptScore W3127262560C103697762 @default.
• W3127262560 hasConceptScore W3127262560C104317684 @default.

• next